🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted steps to address household expense issues" in the forthcoming Budget.

During an interview with media outlets, she emphasized that curbing price rises is a collective responsibility of both the administration and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the G7 advanced economies this year and next.

Possible Utility Bill Measures

It is understood the administration could take action to reduce energy bills, for example by reducing the current 5% rate of VAT charged on energy supplies.

Another possibility is to lower some of the government charges presently included in household expenses.

Fiscal Limitations and Analyst Predictions

The government will obtain the next assessment from the official forecaster, the OBR, on the start of the week, which will clarify how much space there is for these actions.

The consensus from most experts is that Reeves will have to declare tax rises or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Earlier on the same day, analysis indicated there was a £22bn gap for the chancellor to resolve, which is at the more modest range of expectations.

"It is a shared task between the Bank of England and the administration to continue tackling some of the drivers of inflation," the Chancellor stated to the BBC in the US capital, at the conferences of the IMF and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the focus has been on likely tax increases, the chancellor said the most recent figures from the OBR had not changed her vow to election pledges not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with increasing geopolitical and trade issues for the Budget tax moves, probably to be focused on those "wealthiest."

Global Trade Disputes

Referring to worries about the UK's commercial links with China she said: "Our national security always take priority."

Last week's announcement by China to strengthen trade restrictions on critical minerals and other materials that are key for high-technology manufacturing led American leader the US President to threaten an further 100% import tax on imports from the Asian country, raising the possibility of an full-scale trade war between the two economic giants.

The American finance chief labeled China's decision "economic coercion" and "a international production power grab."

Asked about considering the US offer to join its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "bad for the international commerce and generates additional challenges."

"It is my opinion there are areas where we must challenge Chinese policies, but there are also important opportunities to sell into China's economy, including financial services and other areas of the economy. We've got to get that balance appropriate."

The chancellor also affirmed she was cooperating with other major economies "on our own essential resources plan, so that we are less reliant."

Health Service Medicine Pricing and Investment

The Chancellor also admitted that the price the National Health Service pays for drugs could increase as a consequence of ongoing talks with the Trump administration and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or scrapping investments in the UK, with some attributing the modest returns they are receiving.

Recently, the government science advisor said the price the NHS spends on drugs would must increase to stop businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor told the BBC: "It has been observed due to the payment system, that medical research, innovative medicines have not been provided in the UK in the extent that they are in other continental states."

"We want to guarantee that individuals getting treatment from the NHS are able to access the top critical drugs in the globe. And so we are looking at this situation, and... seeking to obtain increased funding into Britain."